Get Started Exscientia - Request Demo

Artificial Intelligence | Machine Learning | Machine Perception Exscientia | Accelerate Drug Discovery & Development

Enterprise, Biotechnology, Pharmaceuticals & Medical Product, Drug Design, Small Molecules Oxford, Oxfordshire, United Kingdom

Artificial Intelligence | Machine Learning | Machine Perception

Exscientia | Accelerate Drug Discovery & Development

Biotechnology, Pharmaceuticals & Medical Product, Drug Design, Small Molecules

Oxford, Oxfordshire, United Kingdom

We are the leading pharma tech company and the first to automate drug discovery. Our aim is to make safer, more sophisticated drugs available to all - more quickly and efficiently than ever before

At the forefront of small molecule drug discovery, We are the first company to automate drug design, surpassing conventional human endeavor. Our AI-driven systems actively learn best practices from vast repositories of discovery data and are further enhanced with knowledge acquired from seasoned drug hunters. With better information to hand than any researcher could acquire individually, our knowledge-driven systems design millions of novel, project-specific compounds and pre-assess each for predicted potency, selectivity, ADME, and other key criteria. From this, a selection of the best, information-rich compounds is selected for synthesis and assay.

Total Funding: $103,671,986

Funding Stage: Series C

Business Stage: N/A

Market: B2B

Company Size: 26 to 50

Founded: 2012

Feb 2021

Exscientia and the University of Oxford Announce Partnership to Develop Treatments for Alzheimer?s Disease

Nov 2018

Exscientia Acquired Kinetic Discovery Ltd. for an Undisclosed Amount

Oct 2017

Exscientia Wins Best Emerging Biotech Company Award at OBN Annual Awards 2017

AI/ML Startup DealsGet Free Access

Date

Round

$ Raised

Investors

04/27/2021

Series D

$225M

CMC Capital Group, CMC Capital Group, Pivotal bioVenture Partners, Pivotal bioVenture Partners, Novo Holdings, Marshall Wace, Marshall Wace, Mubadala Capital Ventures, Mubadala Capital Ventures, Laurion Capital Management, Laurion Capital Management, GT Healthcare Capital, GT Healthcare Capital, Farallon Capital Management, Farallon Capital Management, Casdin Capital, Casdin Capital, BlackRock Private Equity Partners,, BlackRock Private Equity Partners,

Date : 04/27/2021

Round: Series D

$ Raised: $225M

Investors: CMC Capital Group, CMC Capital Group, Pivotal bioVenture Partners, Pivotal bioVenture Partners, Novo Holdings, Marshall Wace, Marshall Wace, Mubadala Capital Ventures, Mubadala Capital Ventures, Laurion Capital Management, Laurion Capital Management, GT Healthcare Capital, GT Healthcare Capital, Farallon Capital Management, Farallon Capital Management, Casdin Capital, Casdin Capital, BlackRock Private Equity Partners,, BlackRock Private Equity Partners,

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

Signup and Get Started

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Exscientia